Sanofi (SNY) Short term Debt (2009 - 2025)

Sanofi (SNY) has 17 years of Short term Debt data on file, last reported at $5.1 billion in Q4 2025.

• Quarterly Short term Debt rose 12.37% year-over-year to $5.1 billion in Q4 2025, while the trailing twelve-month figure through Dec 2025 was $5.1 billion (up 12.37% YoY) and the FY2025 annual result came in at $5.1 billion, up 12.37% from the prior year.
• Short term Debt eased to $5.1 billion in Q4 2025 per SNY's latest filing, from $8.3 billion in the prior quarter.
• The five-year high for Short term Debt was $9.9 billion in Q2 2024, with the low at $2.2 billion in Q4 2023.
• Average Short term Debt over 5 years is $4.9 billion, with a median of $4.4 billion recorded in 2024.
• Year-over-year, Short term Debt sank 48.33% in 2023 and jumped 104.41% in 2024.
• Sanofi's Short term Debt stood at $3.6 billion in 2021, then rose by 16.95% to $4.3 billion in 2022, then tumbled by 48.33% to $2.2 billion in 2023, then soared by 104.41% to $4.5 billion in 2024, then grew by 12.37% to $5.1 billion in 2025.
• Business Quant data shows SNY's Short term Debt at $5.1 billion in Q4 2025, $8.3 billion in Q2 2025, and $4.5 billion in Q4 2024.